Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Glyko Biomedical

Glyko Biomedical
1992 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
2 INVESTMENTS
Description

Provider of biomedical research services. The company provides scientific research services regarding biotechnology and pharmaceuticals.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 371 Bel Marin Keys Boulevard
  • Suite 210
  • Novato, CA 94949
  • United States

Glyko Biomedical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Glyko Biomedical‘s full profile, request access.

Request full access to PitchBook

Glyko Biomedical Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 15-Jul-1998 00 000000000000000 0000 Therapeutic Devices
BioMarin Pharmaceutical 01-Jan-1996 Seed Round Therapeutic Devices
To view this company’s complete investment and acquisition history, request access »

Glyko Biomedical Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 000000000 15-Jul-1998 00 000000000000000 0000 Completed
  • 6 buyers
BioMarin Pharmaceutical 01-Jan-1996 Seed Round Completed
  • 3 buyers
To view this company’s complete exits history, request access »

Glyko Biomedical Executive Team (2)

Name Title Board
Seat
Contact
Info
John Glass President & Chief Executive Officer
Brian Bradley Ph.D Managing Director